Frigola A, Angeloni S, Cerqueti A R
J Clin Pathol. 1979 Jan;32(1):21-5. doi: 10.1136/jcp.32.1.21.
Plasma antithrombin activity was measured using an amidolytic method (substrate Chromozym TH) and a clotting method. The mean antithrombin values found in 76 hospital outpatients were 9.4 micronmol/min/ml with the amidolytic procedure and 100.1% of antithrombin activity with the clotting procedure. The two methods correlate fairly well (r = 0.85, P less than 0.01) and show satisfactory reproducibility. Coefficients of variation of 5.9% and 8.8% were obtained respectively with the amidolytic and the clotting procedures. In the presence of very high levels of fibrinogen degradation products, falsely elevated antithrombin activity levels were observed with the clotting procedure but the amidolytic method is essentially unaffected. It is concluded that both methods are suitable for determining antithrombin activity but a well-standardised amidolytic procedure has advantages.
采用酰胺水解法(底物Chromozym TH)和凝血法测定血浆抗凝血酶活性。76例医院门诊患者中,酰胺水解法测得的抗凝血酶平均值为9.4微摩尔/分钟/毫升,凝血法测得的抗凝血酶活性为100.1%。两种方法相关性良好(r = 0.85,P < 0.01),且具有良好的重复性。酰胺水解法和凝血法的变异系数分别为5.9%和8.8%。在纤维蛋白原降解产物水平非常高的情况下,凝血法会观察到抗凝血酶活性水平假性升高,但酰胺水解法基本不受影响。结论是两种方法都适用于测定抗凝血酶活性,但标准化良好的酰胺水解法具有优势。